Could HPV Be a Silent Contributor to Prostate Cancer Risk? New Study Reveals a 2.3 Times Increase in Associati

In a breakthrough study featured in the journal Prostate Cancer and Prostatic Diseases, researchers have uncovered a significant link between human papillomavirus (HPV) infections and prostate cancer. Examining a substantial cohort of over 20,000 Taiwanese patients, including 5,137 with prostate cancer and 15,411 controls, the study revealed that 14.5% of prostate cancer patients had a prior clinical diagnosis of HPV.

The findings underscore a compelling 2.3-fold increase in the risk of developing prostate cancer for individuals with a history of HPV infections compared to those without. This reinforces a growing body of evidence suggesting a close association between these conditions.

Also Read: Health Ministry Issues Urgent Advisory as BA.2.86 – JN.1 Variant Fuels, Urge to Take Precautions

Given the nearly ubiquitous prevalence of HPV in men, affecting 90% of sexually active males at least once in their lives, the study advocates urgent measures to curb the spread of the virus. The aim is to mitigate the risk of prostate cancer and other associated malignancies, emphasising the need for public health initiatives to address this critical health concern.